A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC / FEC as Neoadjuvant Therapy in Patients with Operable HER2âNegative Breast Cancer
Lim, Bora, Song, Juhee, Ibrahim, Nuhad K., Koenig, Kimberly B., ChavezâMacGregor, Mariana, Ensor, Joe E., Gomez, Jill Schwartz, Krishnamurthy, Savitri, Caudle, Abigail S., Shaitelman, Simona F., WhiJournal:
The Oncologist
DOI:
10.1002/onco.13581
Date:
November, 2020
File:
PDF, 2.09 MB
2020